Johan Dahlberg - Arcoma AB Chief Officer

All Insiders . Sweden . 
Stock . Arcoma AB . Stakeholders . Insider . Johan Dahlberg
ARCOMA Stock  SEK 10.45  0.20  1.88%   

Insider

Johan Dahlberg is Chief Officer of Arcoma AB
Age 39
Phone46 4 70 70 69 00
Webhttps://www.arcoma.se

Arcoma AB Management Efficiency

The company has return on total asset (ROA) of 0.0218 % which means that it generated a profit of $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0423 %, meaning that it generated $0.0423 on every $100 dollars invested by stockholders. Arcoma AB's management efficiency ratios could be used to measure how well Arcoma AB manages its routine affairs as well as how well it operates its assets and liabilities.
Arcoma AB has accumulated 1.81 M in total debt with debt to equity ratio (D/E) of 0.43, which is about average as compared to similar companies. Arcoma AB has a current ratio of 1.43, which is within standard range for the sector. Debt can assist Arcoma AB until it has trouble settling it off, either with new capital or with free cash flow. So, Arcoma AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Arcoma AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Arcoma to invest in growth at high rates of return. When we think about Arcoma AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Lisa LogrenAvensia publ AB
N/A
Jane WallDignitana AB
N/A
Andreas WullrichAvensia publ AB
N/A
Jrgen BertilssonAvensia publ AB
51
Catarina LwenadlerDignitana AB
N/A
Susanne AhlbergGenovis AB
66
John AndersonStille AB
48
Christian LindgrenDignitana AB
49
Linda AnderssonGenovis AB
47
Gunilla SavringaXichem AB
61
Rikke RytterGenovis AB
56
Magnus LangbergGenovis AB
52
Anette CronstroemDignitana AB
N/A
Hanna WilkmanStille AB
56
Maria EdholmGenovis AB
N/A
Niklas CarlnStille AB
49
BA BAGenovis AB
N/A
Johan JohanssonDignitana AB
N/A
Fredrik OlssonGenovis AB
52
Lucas AltepostaXichem AB
56
Ulf JonssonDignitana AB
N/A
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscleskeleton, thoratic, pediatric, and traumaresus clinics. Arcoma AB is traded on Stockholm Stock Exchange in Sweden. Arcoma AB (ARCOMA) is traded on Stockholm Exchange in Sweden and employs 24 people.

Management Performance

Return On Equity0.0423
Return On Asset0.0218

Arcoma AB Leadership Team

Elected by the shareholders, the Arcoma AB's board of directors comprises two types of representatives: Arcoma AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arcoma. The board's role is to monitor Arcoma AB's management team and ensure that shareholders' interests are well served. Arcoma AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arcoma AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frida Robbe, Marketing Mang
Sanna Rydberg, Chief Officer
Johan Dahlberg, Chief Officer
Peter Reinli, Pres IMIX ADR Ltd
Nicklas Johansson, Operations Manager

Arcoma Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arcoma AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0423
Return On Asset0.0218
Profit Margin0.01 %
Operating Margin0.02 %
Current Valuation112.49 M
Shares Outstanding13.05 M
Shares Owned By Insiders46.73 %
Shares Owned By Institutions25.01 %
Price To Earning70.28 X
Price To Book2.26 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Arcoma Stock

Arcoma AB financial ratios help investors to determine whether Arcoma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arcoma with respect to the benefits of owning Arcoma AB security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY